Common Contracts
1 similar Shared Care Agreement contracts
NORFOLK AND WAVENEY STP THERAPEUTICS ADVISORY GROUP (TAG) SHARED CARE AGREEMENT FRAMEWORKShared Care Agreement • December 7th, 2023
Shared Care Agreement for initiation of Guanfacine in children and continuation into adulthood Monitoring Level 1 - Prescribe the drug and perform a higher level of monitoring, e.g. 6-monthly SUMMARY FRONT SHEET – SEE MAIN BODY OF DOCUMENT FOR FULL INFORMATION Generic and Proprietary/Brand Name Guanfacine (Intuniv®) Indications for shared care • Licensed use - Treatment of ADHD in children and adolescents where stimulants are not suitable, not tolerated or ineffective.• Locally-agreed off-label use - Continuing treatment in adults whose symptoms persist and who have shown clear benefit from treatment. See below for further details.• Guanfacine must not be initiated in new adult patients. Specialist Prescribing and Monitoring Responsibilities (full details below) GP / Community Team - Primary Care Prescribing and Monitoring Responsibilities (full details below) • Diagnose patient and provide information.• Ensure the patient understands treatment may be stopped if they do not attend for
